{"id":332798,"date":"2026-10-29T18:02:58","date_gmt":"2026-10-29T12:32:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/bharat-parenterals-q2-results-fy27-pat-12-crore\/"},"modified":"2026-10-29T18:02:58","modified_gmt":"2026-10-29T12:32:58","slug":"bharat-parenterals-q2-results-fy27-pat-12-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bharat-parenterals-q2-results-fy27-pat-12-crore\/","title":{"rendered":"Bharat Parenterals Q2 Results FY27: Revenue Up 110.89% to Rs 136.28 Cr, PAT Rs 11.82 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Bharat Parenterals Q2 Results FY27 were declared on 29 October 2026, with consolidated revenue of Rs 136.28 Cr, up 110.89% from Rs 64.62 Cr a year earlier. Net profit was Rs 11.82 Cr against a loss of Rs 8.60 Cr in the same quarter last year. These quarterly results show YoY growth in revenue and in Operating Profit, which reached Rs 23.58 Cr. All figures are on a Consolidated basis.<\/p>\n<\/div>\n

Bharat Parenterals Ltd<\/a> (BPLPHARMA) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought revenue of Rs 136.28 Cr and PAT of Rs 11.82 Cr, and Bharat Parenterals Q2 Results FY27 are read here on a Consolidated basis against the year-ago quarter. These consolidated results frame everything that follows.<\/p>\n

This Bharat Parenterals Q2 Results article covers the financial highlights, business drivers, outlook and risks, and the results analysis uses only the filed figures. Readers can follow later filings through the Univest Screener. The Financial Highlights come first.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n